Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
REDWOOD CITY, Calif., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that data from its pivotal Phase 3 clinical trial of patiromer, the...
-
REDWOOD CITY, Calif., Sept. 3, 2014 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Relypsa, Inc. (Nasdaq:RLYP), please note that the conference time listed in the...
-
REDWOOD CITY, Calif., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that John Orwin, Chief Executive Officer, will present a corporate...
-
REDWOOD CITY, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2014. Net loss...
-
REDWOOD CITY, Calif., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that John Orwin, Chief Executive Officer, will present a corporate...
-
REDWOOD CITY, Calif., June 19, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the election of Daniel K. Spiegelman, executive vice president and...
-
REDWOOD CITY, Calif., June 2, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced it has secured a loan facility of up to $35 million with Oxford Finance...
-
REDWOOD CITY, Calif., May 20, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that it has entered into a multi-year commercial manufacturing and...
-
REDWOOD CITY, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced topline results from its Phase 1 onset-of-action study of patiromer,...
-
REDWOOD CITY, Calif., May 7, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today reported financial results for the first quarter ended March 31, 2014. Net loss...